Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline

Por de Jong, E, Haverkort, ME, ter Heine, R, Jansen, RS, Beijnen, JH, van Agtmael, MA
Publicado em 2010

Penetration of Atazanavir in Seminal Plasma of Men Infected with Human Immunodeficiency Virus Type 1

Por van Leeuwen, E., ter Heine, R., van der Veen, F., Repping, S., Beijnen, J. H., Prins, J. M.
Publicado em 2007

Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir

Por van Waterschoot, RAB, ter Heine, R, Wagenaar, E, van der Kruijssen, CMM, Rooswinkel, RW, Huitema, ADR, Beijnen, JH, Schinkel, AH
Publicado em 2010

Towards better dose individualisation: metabolic phenotyping to predict cabazitaxel pharmacokinetics in men with prostate cancer

Por Janssen, A, Verkleij, C P M, van der Vlist, A, Mathijssen, R H J, Bloemendal, H J, ter Heine, R
Publicado no Br J Cancer (2017)

A pharmacological rationale for improved everolimus dosing in oncology and transplant patients

Por ter Heine, R., van Erp, N. P., Guchelaar, H. J., de Fijter, J. W., Reinders, M. E. J., van Herpen, C. M., Burger, D. M., Moes, D. J. A. R.
Publicado no Br J Clin Pharmacol (2018)

REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study— protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study

Por Schijvens, A M, Dorresteijn, E M, Roeleveld, N, ter Heine, R, van Wijk, J A E, Bouts, A H M, Keijzer-Veen, M G, van de Kar, N C A J, van den Heuvel, L P W J, Schreuder, M F
Publicado no BMJ Open (2017)